165 related articles for article (PubMed ID: 8166126)
1. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer.
Rosenberg L; Palmer JR; Zauber AG; Warshauer ME; Lewis JL; Strom BL; Harlap S; Shapiro S
Am J Epidemiol; 1994 Apr; 139(7):654-61. PubMed ID: 8166126
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer before age 45 and oral contraceptive use: new findings.
Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S
Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of oral contraceptive use and risk of breast cancer.
Rosenberg L; Palmer JR; Rao RS; Zauber AG; Strom BL; Warshauer ME; Harlap S; Shapiro S
Am J Epidemiol; 1996 Jan; 143(1):25-37. PubMed ID: 8533744
[TBL] [Abstract][Full Text] [Related]
4. Epithelial ovarian cancer and combination oral contraceptives.
Rosenberg L; Shapiro S; Slone D; Kaufman DW; Helmrich SP; Miettinen OS; Stolley PD; Rosenshein NB; Schottenfeld D; Engle RL
JAMA; 1982 Jun; 247(23):3210-2. PubMed ID: 7045417
[TBL] [Abstract][Full Text] [Related]
5. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
[TBL] [Abstract][Full Text] [Related]
6. Events of reproductive life and the incidence of epithelial ovarian cancer.
Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
[TBL] [Abstract][Full Text] [Related]
7. The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk.
Harlow BL; Cramer DW; Geller J; Willett WC; Bell DA; Welch WR
Am J Epidemiol; 1991 Sep; 134(5):445-53. PubMed ID: 1897499
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer.
Gwinn ML; Lee NC; Rhodes PH; Layde PM; Rubin GL
J Clin Epidemiol; 1990; 43(6):559-68. PubMed ID: 2348208
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
10. The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age.
Villard-Mackintosh L; Vessey MP; Jones L
Br J Obstet Gynaecol; 1989 Jul; 96(7):783-8. PubMed ID: 2788456
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking and the risk of epithelial ovarian cancer.
Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM
Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives and ovarian cancer: an update, 1998-2004.
La Vecchia C
Eur J Cancer Prev; 2006 Apr; 15(2):117-24. PubMed ID: 16523008
[TBL] [Abstract][Full Text] [Related]
13. Parity, contraception, infertility, and the risk of epithelial ovarian cancer.
Risch HA; Marrett LD; Howe GR
Am J Epidemiol; 1994 Oct; 140(7):585-97. PubMed ID: 7942759
[TBL] [Abstract][Full Text] [Related]
14. An epidemiologic case-control study of ovarian cancer and reproductive factors.
Nasca PC; Greenwald P; Chorost S; Richart R; Caputo T
Am J Epidemiol; 1984 May; 119(5):705-13. PubMed ID: 6539067
[TBL] [Abstract][Full Text] [Related]
15. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
[TBL] [Abstract][Full Text] [Related]
16. A case-control study of the risk of breast cancer in relation to oral contraceptive use.
Rosenberg L; Palmer JR; Clarke EA; Shapiro S
Am J Epidemiol; 1992 Dec; 136(12):1437-44. PubMed ID: 1288273
[TBL] [Abstract][Full Text] [Related]
17. Parity and Oral Contraceptive Use in Relation to Ovarian Cancer Risk in Older Women.
McGuire V; Hartge P; Liao LM; Sinha R; Bernstein L; Canchola AJ; Anderson GL; Stefanick ML; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1059-63. PubMed ID: 27197274
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and neoplasia of the ovary.
Stanford JL
Contraception; 1991 Jun; 43(6):543-56. PubMed ID: 1868732
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives and breast cancer risk among younger women.
Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
[TBL] [Abstract][Full Text] [Related]
20. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
